William Plovanic
Stock Analyst at Canaccord Genuity
(3.29)
# 944
Out of 4,898 analysts
132
Total ratings
42.86%
Success rate
3.69%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AORT Artivion | Initiates: Buy | $35 | $31.67 | +10.51% | 1 | Jun 17, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Hold | $115 → $101 | $93.78 | +7.70% | 3 | May 12, 2025 | |
| IRTC iRhythm Technologies | Maintains: Buy | $152 → $139 | $139.23 | -0.17% | 10 | May 2, 2025 | |
| DXCM DexCom | Maintains: Buy | $103 → $106 | $85.05 | +24.63% | 6 | May 2, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $58 → $59 | $15.83 | +272.83% | 4 | May 1, 2025 | |
| EW Edwards Lifesciences | Maintains: Hold | $71 → $75 | $78.14 | -4.02% | 26 | Apr 25, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $23 → $18 | $7.40 | +143.41% | 8 | Apr 8, 2025 | |
| TLSI TriSalus Life Sciences | Maintains: Buy | $11 | $4.98 | +120.88% | 4 | Mar 28, 2025 | |
| ATRC AtriCure | Maintains: Buy | $66 → $52 | $31.19 | +66.72% | 11 | Mar 28, 2025 | |
| TMDX TransMedics Group | Maintains: Buy | $104 | $116.32 | -10.59% | 5 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $8 | $3.87 | +106.72% | 3 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 | $16.39 | +101.34% | 4 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $92 → $101 | $57.36 | +76.08% | 3 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $9.52 | +57.56% | 6 | Jan 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $269 → $304 | $292.74 | +3.85% | 3 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $101 | $104.31 | -3.17% | 9 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $6.80 | +120.59% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $238.23 | +19.22% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $10.92 | +128.94% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $2.68 | +347.76% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $93.38 | -25.04% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $17.29 | +177.62% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $4.37 | +403.43% | 3 | Jul 25, 2023 |
Artivion
Jun 17, 2025
Initiates: Buy
Price Target: $35
Current: $31.67
Upside: +10.51%
Zimmer Biomet Holdings
May 12, 2025
Maintains: Hold
Price Target: $115 → $101
Current: $93.78
Upside: +7.70%
iRhythm Technologies
May 2, 2025
Maintains: Buy
Price Target: $152 → $139
Current: $139.23
Upside: -0.17%
DexCom
May 2, 2025
Maintains: Buy
Price Target: $103 → $106
Current: $85.05
Upside: +24.63%
Tandem Diabetes Care
May 1, 2025
Maintains: Buy
Price Target: $58 → $59
Current: $15.83
Upside: +272.83%
Edwards Lifesciences
Apr 25, 2025
Maintains: Hold
Price Target: $71 → $75
Current: $78.14
Upside: -4.02%
CVRx, Inc.
Apr 8, 2025
Maintains: Buy
Price Target: $23 → $18
Current: $7.40
Upside: +143.41%
TriSalus Life Sciences
Mar 28, 2025
Maintains: Buy
Price Target: $11
Current: $4.98
Upside: +120.88%
AtriCure
Mar 28, 2025
Maintains: Buy
Price Target: $66 → $52
Current: $31.19
Upside: +66.72%
TransMedics Group
Mar 11, 2025
Maintains: Buy
Price Target: $104
Current: $116.32
Upside: -10.59%
Mar 5, 2025
Maintains: Buy
Price Target: $5 → $8
Current: $3.87
Upside: +106.72%
Feb 26, 2025
Maintains: Buy
Price Target: $33
Current: $16.39
Upside: +101.34%
Jan 10, 2025
Maintains: Buy
Price Target: $92 → $101
Current: $57.36
Upside: +76.08%
Jan 9, 2025
Maintains: Buy
Price Target: $12 → $15
Current: $9.52
Upside: +57.56%
Dec 9, 2024
Maintains: Buy
Price Target: $269 → $304
Current: $292.74
Upside: +3.85%
Dec 9, 2024
Maintains: Buy
Price Target: $98 → $101
Current: $104.31
Upside: -3.17%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $6.80
Upside: +120.59%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $238.23
Upside: +19.22%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $10.92
Upside: +128.94%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $2.68
Upside: +347.76%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $93.38
Upside: -25.04%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $17.29
Upside: +177.62%
Jul 25, 2023
Maintains: Buy
Price Target: $21 → $22
Current: $4.37
Upside: +403.43%